The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Hepatitis C Hope

Back to News Homepage

Next

HCV Treatment Clincal Trial Announcement

New National HCV Initiative

July 19, 2005

Print this page

It always does my heart well when more information is getting out there to the general public about Hepatitis c.

Health Centers Mobilize Against a ‘Silent Killer’

Tuesday July 19, 10:20 am ET
New National Initiative Targets Hepatitis C (HCV) Infection

WASHINGTON, July 19 /PRNewswire/ — The National Association of Community Health Centers (NACHC), has launched a new initiative against the “silent killer” Hepatitis C (HCV), concentrating efforts through local health care centers and seeking to treat patients before they develop potentially life- threatening symptoms. Among the chronically infected, nearly 70% of patients will develop chronic liver disease, with Hepatitis C being the leading cause of liver transplants in the United States. Kicked off this week in Denver, Colorado, with a national HCV Educational Symposium for project participants, sponsored by The National Association of Community Health Centers (NACHC), the program is rolling out nationally to pilot programs in six U.S. cities.

HCV is described as a “silent epidemic” because most people who are infected will carry the virus for years without knowing it. The disease is responsible for an estimated 10,000 US deaths a year – a number that the Centers for Disease Control and Prevention (CDC) projects will double or triple as people infected decades ago develop more debilitating symptoms.

The Denver symposium lays the groundwork for select health centers throughout the country to develop aggressive clinical strategies against the disease. Working in conjunction with the Denver-based Liver Research Institute (LRI), NACHC will conduct pilot programs in six U.S. cities. After completing the program, health center clinical providers will have the capacity to treat HCV on-site at the patients’ medical home. NACHC expects the on-site treatment will lead to improved adherence to the rigorous treatment protocol and enable more health center HCV patients to receive care.

“It is appropriate that the health centers are a staging area for the battle against HCV,” stated Tom Curtin, MD, the Vice President for Clinical Affairs at NACHC. “Health centers have compiled an impressive record of success in the prevention and early detection of diseases over the last 40 years. They are uniquely designed for this intervention effort because they are community-based; they understand their patient population and, more importantly, the foundation necessary to conduct outreach and early intervention is already in place.”

The Liver Research Institute (LRI) is committed to understanding the natural history of liver disease and the development and evaluation of new therapies. LRI is involved in educational activities to increase awareness and improve outcomes.

“We are excited to be working with NACHC to bring together both clinical expertise and practical tools for health centers in the fight against Hepatitis C,” said Stephen Steinberg, MD, Medical Director of the Liver Research Institute.

The second phase of the project includes a three day training program guided by local HCV experts. The national HCV initiative provides select health centers with the state-of-the-art tools and clinical training to expand HCV early intervention and treatment. Each health center will receive clinical education and training, as well as resources to help integrate a treatment strategy in their existing clinical setting. Clinical teams from participating health centers include those from Miami, FL, Houston, TX, New York City, NY, Baltimore, MD, Los Angeles, CA, and Denver/Fort Lupton, CO.

The launch of the initiative comes as the CDC estimates that nearly four million Americans are infected by HCV, with new infections expected to grow at a rate of 30,000 a year. HCV sufferers can develop liver diseases that impair function, such as liver cancer or cirrhosis — conditions that are ultimately fatal.

Health centers are the medical home to nearly 15 million Americans, many of whom are low-income and/or uninsured and at high risk for HCV infection. For more information about health centers or NACHC, visit http://www.nachc.com.

Established in 1971, NACHC is a non-profit organization whose mission is (1) to represent the interests of federally supported and other federally qualified health centers and (2) to serve as an information source concerning issues of health care for poor and medically underserved populations in the United States.

1 Comment
Share
Share

Previous

Hepatitis C Hope

Back to News Homepage

Next

HCV Treatment Clincal Trial Announcement

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.

  • Jerry

    Ralph thanks for letting me know more than my Dr. has.God has helped me greatly in this sicknes.I will continue to read your news letters as this one has opened my eyes to more kinds of treatment Peg-Intron,Ribavirin has put me in the hospital twice. please stay in touch with better treatments. Again THANKS.